The Javelin IVL catheter "has the ability to transform the way that physicians are able to treat patients,” Shockwave CMO Dr. Nick West said.

Coinciding with the FDA’s clearance for the catheter, Perfuze has also completed a €22m ($24m) financing round.

Perfuze, an Ireland-based developer of catheter-based aspiration technology for the treatment of acute ischemic stroke, ...

The global IV therapy and vein access devices market is on a trajectory of significant growth, projected to expand from USD 28.7 billion in 2024 to an estimated USD 47.3 billion by 2034. With a ...

What significant advancements have been observed in the specialty catheters market? The specialty catheters market size has grown strongly in recent years, evolving from $6.34 billion in 2024 to ...

The company provided 2025 EBITDA guidance of $3.2 billion to $3.4 billion and free ... of improved revenue mix and cost takeout, we see Lumen returning to full-year EBITDA growth in 2026." ...

The multi-lumen CIVCs provide multiple access to the central vein for intravenous therapy. The market is growing faster as they facilitate multiple channels to administer many drugs and minimize the ...

When CRBSI is suspected in the presence of a multilumen catheter, each lumen should be considered a ... biofilm colonization in 1, 2, and 3 lumens in 10 (40%), 10 (40%), or 5 (20%) cases ...

Frequent or unnecessary central venous catheter insertions should be avoided, as this exposes the patient to potential risks such as thrombosis and stenosis of the vessels leading to the superior ...